The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 03, 2016
Filed:
Feb. 24, 2011
Applicants:
Jatin Patel, West Windsor, NJ (US);
Charles Frost, Yardley, PA (US);
Jingpin Jia, Belle Mead, NJ (US);
Chandra Vemavarapu, Hillsborough, NJ (US);
Inventors:
Jatin Patel, West Windsor, NJ (US);
Charles Frost, Yardley, PA (US);
Jingpin Jia, Belle Mead, NJ (US);
Chandra Vemavarapu, Hillsborough, NJ (US);
Assignees:
Bristol-Myers Squibb Company, Princeton, NJ (US);
Pfizer Inc., New York, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 31/4545 (2006.01); A61K 31/437 (2006.01); A61K 31/4412 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2018 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 9/2095 (2013.01); A61K 31/4545 (2013.01); A61K 31/437 (2013.01); A61K 31/4412 (2013.01);
Abstract
Compositions comprising crystalline apixaban particles having a Dequal to or less than 89 μm, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.